Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

METOTREXATO SEMANAL WYETH 2,5 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/METOTREXATO SEMANAL WYETH 2,5 MG COMPRIMIDOS

Approved

STANDARD

METOTREXATO SEMANAL WYETH 2,5 MG COMPRIMIDOS

Wyeth Farma S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Oct 16, 2020
Approval ID: 7e4dc60d67fde967
Company: Wyeth Farma S.A.
Type: Standard

Approval Details

Approval Id: 7e4dc60d67fde967
Drug Cima Aemps Name: METOTREXATO SEMANAL WYETH 2,5 MG COMPRIMIDOS
Register Number: 85482
Holder Company Name: Wyeth Farma S.A.
Marketing Company Name: Pfizer S.L.
Authorization Date: 2020-10-16
Dosage Form: COMPRIMIDO
Dose: 2,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Wyeth Farma S.A.

Active Ingredients

METOTREXATO SODIO

2,5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 16, 2020

Approval ID

7e4dc60d67fde967

Type

Standard

Back to CIMA-AEMPS Approvals